Zobrazeno 1 - 4
of 4
pro vyhledávání: '"A. A. Mukhomed'yarova"'
Autor:
B. Ya. Alekseev, A. S. Kalpinskiy, I. A. Taraki, A. A. Mukhomed’yarova, K. М. Nyushko, N. V. Vorobyev, A. A. Kostin, A. D. Kaprin
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 4, Iss 2, Pp 54-60 (2017)
Renal cell carcinoma (RCC) occupies one of the leading places in the world for morbidity among malignant neoplasms of the genitourinary system. The frequency of occurrence of bilateral RCC according to different authors is 2–6% of the total populat
Externí odkaz:
https://doaj.org/article/11f8df3f676c470d89f95550169e2ff0
Autor:
A. P. Polyakov, I. V. Reshetov, A. M. Zaytsev, M. V. Ratushnyi, O. V. Matorin, M. M. Filyushin, F. E. Sevryukov, N. V. Babaskina, Yu. A. anaseikin, A. L. Sugaipov, A. A. Mukhomed'yarova, A. D. Kaprin
Publikováno v:
Опухоли головы и шеи, Vol 5, Iss 3, Pp 16-23 (2015)
A surgical approach as dysmasking implies a bitemporal skin incision followed by a single flap from upper facial soft tissues. The advantages of this technique may include a wide surgical approach to the structures of the anterior skull base, a possi
Externí odkaz:
https://doaj.org/article/dfdc6079a369405eb1a6b62983f6a89b
Autor:
B. Ya. Alekseev, A. D. Kaprin, G. P. Kolesnikov, A. A. Mukhomed’yarova, E. I. Konopleva, A. S. Kalpinskiy
Publikováno v:
Onkourologiâ, Vol 14, Iss 3, Pp 25-36 (2018)
Over the last 10 years, the capacities of second-line systemic therapy for metastatic renal cell carcinoma (mRCC) changed significantly. Targeted therapy is a standard treatment for patients with mRCC. However, the choice of therapeutic agents for su
Publikováno v:
Onkourologiâ, Vol 13, Iss 2, Pp 49-55 (2017)
The majority of patients with metastatic renal cell carcinoma (mRCC) are in the groups of favorable or moderate prognosis per the MSKCC (MemorialSloan-KetteringCancerCenter) criteria, but in 20–30 % of poor-prognosis patients aggressive, rapidly pr